| Type | Title | Date Released | |
|---|---|---|---|
10-Q | Form 10-Q | ||
8-K | Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance | ||
8-K | Brad Hively to Depart Starling Oncology Board of Directors | ||
4 | Hively Brad (Reporting) | ||
8-K | Starling Oncology, Inc. Enters into $25 Million Revolving Credit Facility | ||
144 | Form 144 | ||
4 | Chernett Jorey (Reporting) | ||
10-Q | Form 10-Q | ||
8-K | Form 8-K | ||
8-K | The Oncology Institute Rebrands to Starling Oncology and Updates Ticker Symbol | ||
4 | Kaushal Mohit (Reporting) | ||
4 | McGeorge Anne (Reporting) |
